Urologische Praxis Herzberg
- Address
- lock Available on a paid plan
Urologische Praxis Herzberg - Bladder Cancer Research
Urologische Praxis Herzberg is a specialized urological practice engaged in clinical research focused on innovative treatment approaches for superficial bladder cancer. The center demonstrates particular expertise in investigating alternative therapeutic modalities for patients with intermediate-risk bladder carcinoma, contributing to the advancement of intravesical therapy options.
- Intravesical mistletoe extract therapy for superficial bladder cancer
- Comparative efficacy studies of novel versus standard chemotherapy agents
- Treatment strategies for intermediate-risk Ta stage bladder tumors
The practice specializes in managing patients with completely resected superficial bladder carcinoma, particularly focusing on Stage Ta tumors classified as intermediate-risk according to European Association of Urology (EAU) guidelines. Their research investigates the prevention of tumor recurrence through innovative intravesical instillation therapies, comparing emerging biological agents with established chemotherapy protocols to optimize patient outcomes and potentially reduce treatment-related side effects.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Urologische Praxis Herzberg
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Intravesical Extract of Fresh Ash Mistletoe Herb Versus Mitomycin C in Intermediate-Risk Superficial Bladder Carcinoma | Abnoba GmbH | Phase III | Not Recruiting | Feb 2015 | Apr 2026 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Extract Of Fresh Ash Mistletoe Herb | 1 | Unknown | 2015-02-11 | 2015-02-11 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.